Company news
Hemogenyx Pharmaceuticals Plc (LSE:HEMO) news
Hemogenyx Pharmaceuticals Plc news releases on 6ix. Latest, Sep 30, 2026: Total Voting Rights
Press releases & updates
Total Voting Rights
September 30, 2026
Hemogenyx Pharmaceuticals PLC Announces Half-year Financial Report
September 28, 2026
Hemogenyx Pharmaceuticals PLC Announces Collaboration with Cellin Technologies
August 11, 2026
Hemogenyx Pharmaceuticals PLC Announces Collaboration and Company Update
July 29, 2026
Hemogenyx Pharmaceuticals PLC Announces Notice of AGM
June 5, 2026
Hemogenyx Pharmaceuticals PLC Announces Grant of Options and Extension of Warrant Term
May 29, 2026
Institutional Fundraise
April 28, 2026
Annual IND Report with FDA
April 14, 2026
Tech Transfer Completion and Clinical Trial Update
March 31, 2026
Total Voting Rights
February 27, 2026
Holding(s) in Company
February 24, 2026
Exercise of Warrants and Issue of Equity
February 23, 2026
CORRECTION FROM SOURCE: Hemogenyx Pharmaceuticals PLC Announces Issue of Equity
February 10, 2026
Hemogenyx Pharmaceuticals PLC Announces Issue of Equity
February 10, 2026
Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares
December 22, 2025
Hemogenyx Pharmaceuticals PLC - Issue of Equity
December 18, 2025
Hemogenyx Pharmaceuticals PLC Announces Publication of Prospectus
November 19, 2025
Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards
October 29, 2025
Hemogenyx Pharmaceuticals PLC Announces Clearance to Initiate Pediatric Enrolment
October 6, 2025
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
September 30, 2025
Hemogenyx Pharmaceuticals PLC Signs Letter of Intent
September 23, 2025
Hemogenyx Pharmaceuticals PLC Announces Third Patient Safety
September 17, 2025
Hemogenyx Pharmaceuticals PLC Announces Invitation to Participate at DCNY Summit
September 11, 2025
Hemogenyx Pharmaceuticals PLC Announces Manufacturing Partnership with Made Scientific
September 8, 2025
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
September 5, 2025
Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes
September 1, 2025
Hemogenyx Pharmaceuticals PLC Announces Result of Audit Tender
August 29, 2025
Hemogenyx raises £570,000 and Director's Dealing
August 26, 2025
Hemogenyx Pharmaceuticals PLC - Third Patient Treated with HG-CT-1 CAR-T Therapy
August 15, 2025
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £250,000 and Director's Dealing
July 29, 2025
Hemogenyx Awarded Grant
July 16, 2025
Hemogenyx Pharmaceuticals PLC Announces Clearance to Proceed with Pediatric Expansion
June 17, 2025
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing
June 3, 2025
Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests
June 3, 2025
Result of AGM
May 29, 2025
Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol
May 14, 2025
AGM Correction
May 13, 2025
Placing to Raise £451,250 and Director’s Dealing
May 8, 2025
Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy
May 2, 2025
Hemogenyx Pharmaceuticals PLC Announces Final Results
April 28, 2025
Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report
April 3, 2025
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
March 31, 2025
Hemogenyx Pharmaceuticals PLC Announces First Patient Safety
March 24, 2025
Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials
March 17, 2025
Conversion of convertible loan notes
March 13, 2025
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
March 11, 2025
Hemogenyx Pharmaceuticals PLC Announces First-in-Human Treatment with HG-CT-1
February 24, 2025
Issue of convertible loan notes
February 19, 2025
Placing to raise £340,000
January 8, 2025
Change of Company Secretary and Registered Office
January 2, 2025